President Trump was talking to reporters Friday after Dr. Oz's swearing-in ceremony when the news conference abruptly ended.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

"We are proud to announce that LifeMD now accepts Medicare Fee-For-Service for qualifying virtual primary care, including such care provided in our weight management program – an important step ...

Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Eli Lilly, maker of Mounjaro, also offers another version of the drug called Zepbound ... as the Centers for Medicare and ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

Eli Lilly and Company’s LLY shares have lost 8.2% in the past month. A lot of this price decline is due to the global ...

Eli Lilly, maker of Mounjaro, also offers another version of the drug called Zepbound ... for Medicare and Medicaid Services said late Friday. Osborn said the move to block coverage likely ...